Bayer CropScience (BAYERCROP) Fundamentals 2026 — P/E 27.9x, Revenue Analysis | SniperIQ
Bayer CropScience (BAYERCROP) is a India-listed Basic Materials company in Agricultural Inputs with a market capitalization of ₹19,274 Crore, trading at ₹4289.50 on the BSE. This SniperIQ fundamentals page covers Bayer CropScience's valuation (P/E 27.9x, P/B 6.5x), profitability (net margin 12.1%), revenue (₹5,675 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Bayer CropScience's market cap?
Bayer CropScience (BAYERCROP) has a market capitalization of approximately ₹19,274 Crore, trading at ₹4289.50 on the BSE. Market cap moves with the live share price.
What is Bayer CropScience's P/E ratio?
Bayer CropScience's trailing twelve-month P/E ratio is 27.9x, with a price-to-book (P/B) of 6.5x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Bayer CropScience?
Bayer CropScience runs a net profit margin of 12.1%, a gross margin of 38.0%, and an operating margin of 19.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Bayer CropScience generate?
Bayer CropScience reported revenue of ₹5,675 Crore for fiscal year 2026, with net income of ₹689 Crore and earnings per share (EPS) of 153.35. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Bayer CropScience pay a dividend?
Bayer CropScience offers a trailing dividend yield of about 2.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Bayer CropScience financially healthy?
Bayer CropScience carries a debt-to-equity ratio of 0.03x and a current ratio of 1.92x, with a market beta of 0.23. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Bayer CropScience a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Bayer CropScience (BAYERCROP) the key facts are: market cap ₹19,274 Crore, P/E 27.9x, revenue ₹5,675 Crore, 52-week range 4030-6539.95. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Bayer CropScience's full fundamentals live
Get Bayer CropScience's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.